Pentagon Study Finds Higher Cancer Rates Among Pilots, Ground Crews
Military pilots and the ground crews who fuel and maintain their aircraft have higher rates of certain cancers, a new study shows.
Diagnosis & Disease Information
Trial Investigating Pembrolizumab for Hormone-Sensitive Prostate Cancer Discontinued
Merck has decided to end the phase 3 KEYNOTE-991 trial due to futility.
Adverse Birth Outcomes More Common Among AYAs With Cancer During Pregnancy
Adolescent and young adult patients diagnosed with cancer during pregnancy have a higher risk of adverse birth outcomes, a study suggests.
Discrimination Tied to Frailty in African-American Cancer Survivors
Among African-American cancer survivors, experiencing discrimination is associated with frailty, a study suggests.
Metastasis-Directed Therapy Protective in Recurrent Prostate Cancer
New findings could have implications for the use of salvage therapies.
Positive Surgical Margins Linked to Worse RCC Recurrence, Survival Rates
Findings may inform treatment decisions after nephrectomy with positive surgical margins.
Survival Improving in Metastatic Bladder Cancer
The median survival for patients with metastatic bladder cancer is increasing, possibly due to increasing use of immunotherapy.
The Cost of Bladder Cancer Care Is Rising. Could Value-Based Care Models Help?
The rising cost of care is having a negative impact on patients with bladder cancer, but a value-based approach to care might provide some relief.
Surgery, Radiation Therapy Offer Similar Survival in High-Risk Prostate Cancer
Investigators analyzed data from 3 randomized controlled trials and data from their own prospective institutional database.
Fat Loss Portends Worse Prognosis in ICI-Treated Metastatic Clear Cell RCC
Change in subcutaneous fat after initiation of immune checkpoint inhibitors may distinguish which patients will and will not respond to therapy.
- Loading...
Loading...
Next post in Renal Cell Carcinoma
Loading... 
Loading...